A Study of AK112 in Advanced Malignant Tumors

Clinical trial NCT05214482 · COMPLETED

Trial details

NCT number: NCT05214482
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2022-01-22
Primary completion: 2025-11-20
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.